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Wassergefiltertes Infrarot A in Kombination mit sichtbarem Licht hemmt akute 
Chlamydieninfektionen 
 
Neue therapeutische Strategien sind nötig, um die Nachteile der Behandlung von 
intrazellulären, bakteriellen Infektionen zu überwinden. Chlamydiaceae sind Gram-negative 
Bakterien, welche an verschiedenen akuten und chronischen Erkrankungen beteiligt sind. 
Wassergefiltertes Infrarot A (wIRA) weist ein Spektrum von 780 bis 1400 nm auf. Klinische 
Studien haben gezeigt, dass wIRA alleine und in Kombination mit sichtbarem Licht 
(wIRA/VIS) akute und chronische Wundheilungsprozesse positiv beeinflussen kann. Dies ist 
die erste Studie, welche zeigt, dass wIRA/VIS unabhängig von der Zelllinie (Vero, HeLa) und 
des Chlamydienstamms (C. pecorum, C. trachomatis serovar E) die Anzahl an infektiösen 
Elementarkörperchen (EBs) reduzieren kann. Zusätzlich konnte nach einmaliger Bestrahlung 
mit wIRA/VIS 40h nach Infektion (hpi) eine signifikante Reduktion der Anzahl an 
Chlamydieneinschlüssen nachgewiesen werden. Eine dreifache Bestrahlung (24, 36, 40 hpi) 
von C. trachomatis-infizierten Zellen führte zu einer noch stärkeren Reduktion von 
Chlamydieneinschlüssen ohne dabei Persistenz auszulösen. Bestrahlung der Wirtszellen 
führte weder zu einer negativen Beeinflussung der Zellviabilität noch gab es Anzeichen von 
Zytotoxizität. Chlamydieninfektionen, Bestrahlung und die Kombination von beidem lösten 
die gleiche, proinflammatorische Wirtszellantwort aus. Erste Erkenntnisse bezüglich des 
Wirtsmechanismus deuten auf mögliche thermale Effekte infolge Bestrahlung hin. 
 
Stichwörter: Chlamydia, Hyperthermie, VIS, wIRA, Zellstress 
 2 
Vetsuisse Faculty University of Zurich 2014 
 
Hanna Marti 
 
Institute of Veterinary Pathology 
ivpz@vetpath.uzh.ch 
 
Water-filtered infrared A irradiation in combination with visible light inhibits acute 
chlamydial infection 
 
New therapeutic strategies are needed to overcome drawbacks in treatment of infections with 
intracellular bacteria. Chlamydiaceae are Gram-negative bacteria implicated in a variety of 
acute and chronic diseases. Water-filtered infrared A (wIRA) is short wavelength infrared 
radiation with a spectrum ranging from 780 to 1400 nm. In clinical settings, wIRA alone and 
in combination with visible light (VIS) has proven its efficacy in acute and chronic wound 
healing processes. This is the first study to demonstrate that wIRA irradiation combined with 
VIS (wIRA/VIS) diminishes recovery of infectious elementary bodies (EBs) in two different 
cell lines (Vero, HeLa) regardless of the chlamydial strain (C. pecorum, C. trachomatis 
serovar E). Moreover, a single exposure to wIRA/VIS at 40 hours post infection (hpi) led to a 
significant reduction of Chlamydia-infected cells. A triple dose of irradiation (24, 36, 40 hpi) 
during the course of C. trachomatis infection further reduced chlamydial inclusion frequency 
in HeLa cells without inducing the chlamydial persistence/stress response. Irradiation of host 
cells (HeLa, Vero) neither affected cell viability nor induced any molecular markers of 
cytotoxicity. Chlamydial infection, irradiation, and the combination of both showed a similar 
release pattern of a subset of pro-inflammatory cytokines and chemokines from host cells. 
Initial investigation into the mechanism indicated possible thermal effects on Chlamydia due 
to irradiation.  
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Visible Light Inhibits Acute Chlamydial Infection
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Abstract
New therapeutic strategies are needed to overcome drawbacks in treatment of infections with intracellular bacteria.
Chlamydiaceae are Gram-negative bacteria implicated in acute and chronic diseases such as abortion in animals and
trachoma in humans. Water-filtered infrared A (wIRA) is short wavelength infrared radiation with a spectrum ranging from
780 to 1400 nm. In clinical settings, wIRA alone and in combination with visible light (VIS) has proven its efficacy in acute
and chronic wound healing processes. This is the first study to demonstrate that wIRA irradiation combined with VIS (wIRA/
VIS) diminishes recovery of infectious elementary bodies (EBs) of both intra- and extracellular Chlamydia (C.) in two different
cell lines (Vero, HeLa) regardless of the chlamydial strain (C. pecorum, C. trachomatis serovar E) as shown by indirect
immunofluorescence and titration by subpassage. Moreover, a single exposure to wIRA/VIS at 40 hours post infection (hpi)
led to a significant reduction of C. pecorum inclusion frequency in Vero cells and C. trachomatis in HeLa cells, respectively. A
triple dose of irradiation (24, 36, 40 hpi) during the course of C. trachomatis infection further reduced chlamydial inclusion
frequency in HeLa cells without inducing the chlamydial persistence/stress response, as ascertained by electron microscopy.
Irradiation of host cells (HeLa, Vero) neither affected cell viability nor induced any molecular markers of cytotoxicity as
investigated by Alamar blue assay and Western blot analysis. Chlamydial infection, irradiation, and the combination of both
showed a similar release pattern of a subset of pro-inflammatory cytokines (MIF/GIF, Serpin E1, RANTES, IL-6, IL-8) and
chemokines (IL-16, IP-10, ENA-78, MIG, MIP-1a/b) from host cells. Initial investigation into the mechanism indicated possible
thermal effects on Chlamydia due to irradiation. In summary, we demonstrate a non-chemical reduction of chlamydial
infection using the combination of water-filtered infrared A and visible light.
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Introduction
The Chlamydiaceae are implicated in a wide variety of acute and
chronic diseases in both animals and humans [1]. Trachoma
induced by Chlamydia (C.) trachomatis is the leading cause of
preventable blindness of human beings in developing countries.
Other C. trachomatis serovars are the principal bacterial cause for
sexually transmitted diseases leading to sterility in women in
developed countries [2]. C. pecorum is associated with various
diseases ranging from keratoconjunctivits to pneumonia, polyar-
thritis and abortion in swine and ruminants [3]. Unlike most
bacterial species, chlamydiae replicate within a membrane-bound
vacuole termed an inclusion in the cytoplasm of host cells. The
obligate intracellular lifestyle of chlamydiae is characterized by a
biphasic developmental cycle consisting of an infectious and
metabolically less active stage (elementary body or EB), which
differentiates into dividing reticulate bodies (RBs) before trans-
forming back into EBs [4]. Several factors such as exposing acutely
infected cells to IFN-c can induce the persistence/stressed state,
which may enable chlamydiae to withstand hostile conditions
within the cell. Persistence is defined as a viable but non-infectious
developmental state that is: i) reversible once the stressor is
removed; and ii) characterized by the presence of aberrant bodies
(ABs), which show distinct morphological differences compared to
EBs or RBs. Other persistence inducers include deprivation of
glucose, iron or amino acids, and heat shock (reviewed in [5]).
The complex lifestyle of Chlamydiaceae poses challenges to both
diagnosis and treatment of chlamydial infections. Antimicrobial
therapy is the treatment of choice for bacterial infections.
However, in Chlamydia, concerns about the possible development
of resistance during antibiotic therapy have discouraged the use of
certain antimicrobial compounds for chlamydial treatment (i.e.
rifampin resistance in C. trachomatis [6]–[8]). Furthermore, there is
evidence that b-lactam antibiotics induce persistence in vitro as well
as in vivo (reviewed in [9]). Another concern is insufficient
compliance regarding multiple-dose treatment over the course of
several days (reviewed in [10]). New therapeutic strategies are
therefore needed to overcome drawbacks in treatment of
chlamydial infections.
Light of a halogen bulb passing a water-containing cuvette emits
water-filtered infrared A (wIRA) and visible light (VIS) as
previously shown [11]. WIRA is short wavelength infrared
radiation with a spectrum ranging from 780 to 1400 nm. WIRA
alone and in combination with VIS (wIRA/VIS) has been used in
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different clinical settings and its efficacy has been proven in acute
and chronic wound healing processes [12]. Only few preliminary
data on treatment of infectious conditions with wIRA irradiation
have been reported so far. A lower rate of wound infections
following abdominal surgery was observed after post-operative
irradiation with wIRA/VIS compared to treatment with VIS [11].
However, its direct effect on pathogens in vitro and in particular on
obligate intracellular infectious agents such as chlamydiae has not
been shown before.
The aim of this study was to investigate the effect of wIRA/VIS
on Chlamydia, on two types of mammalian host cells and on their
interaction in a cell culture model. Here we demonstrate that EBs
are less infectious after wIRA/VIS treatment compared to non-
treated control EBs regardless of the chlamydial strain. Irradiation
of cells did not induce cytotoxicity even at high wIRA/VIS doses
and long-time exposure. Furthermore, it could be shown that
single-dose irradiation caused a significant reduction of chlamydial
inclusions without inducing persistence. Three-fold irradiation led
to an even more profound reduction. Irradiation and chlamydial
infection triggered an identical host cell response measured by the
release of a cluster of cytokines and chemokines. Finally, heating
experiments resulted in a reduction of the chlamydial burden
comparable to the wIRA/VIS treatment indicating a potential
thermal-induced mode of action.
Materials and Methods
Host cells and media
Vero 76 cells (African green monkey kidney cells, CRL 1587
American Type Culture Collection (ATCC), Manassas, VA, USA)
and HeLa cells (Homo sapiens cervix adenocarcinoma, CCL-2
ATCC) were cultured at 37uC with 5% CO2 in growth culture
medium for cell propagation. Vero growth medium consisted of
Minimal Essential Medium (MEM) with Earle’s salts, 25 mM
HEPES, without L-Glutamine (GIBCO, Invitrogen, Carlsbad,
CA, USA) supplemented with 10% fetal calf serum (FCS,
BioConcept, Allschwil, Switzerland), 4 mM GlutaMAX-I
(200 mM, GIBCO) and 0.2 mg/ml gentamycin (50 mg/ml,
GIBCO). HeLa cell culture media were further supplemented
with 1% MEM Non-Essential Amino Acids (MEM NEAA, 100x,
GIBCO). Medium used for cell propagation intended for infection
experiments was without gentamycin [13]. Cells were seeded on
round glass coverslips (13 mm diameter, Sterilin Limited (Thermo
Fisher Scientific), Cambridge, UK) in 24-well plates (Techno
Plastic Products AG (TPP), Trasadingen, Switzerland) at a density
of 36105/well in 1 mL medium for infection experiments.
Infection experiments were performed when cells reached at least
90% confluency.
Chlamydial strains
In this study, two different strains of Chlamydiaceae were used for
in vitro infection experiments: Chlamydia (C.) pecorum 1710S (isolate
from a swine abortion, kindly provided by Prof. J. Storz, Baton
Rouge, LA, USA) and C. trachomatis serovar E (kindly provided by
Prof. R. V. Schoborg, Johnson City, TN, USA). The isolate of the
C. trachomatis strain was originally obtained from S. P. Wang and
C.-C. Kuo (University of Washington, Seattle, WA, USA).
Subsequently, it was propagated and harvested as previously
described [14]. Briefly, C. trachomatis stocks were propagated in
HEC-1B cells, supplemented with 2 mM glutamine and 10% FCS
for 72 h, harvested in 2-fold sucrose-phosphate-glutamate (SPG)
and stored at 280uC. Stocks of C. pecorum were propagated in
HEp-2 monolayers, purified and stored at280uC in SPG medium
as shown previously [13].
wIRA irradiation
If not stated differently, cultures were exposed to water-filtered
infrared A combined with visible light (wIRA/VIS) for 20 min
using a wIRA radiator (hydrosun 750, Hydrosun GmbH,
Mu¨llheim, Germany) at a dose of 3700 W/m2. The resulting
radiation spectrum ranges from 380 nm up to 1400 nm. The 24-
well plate was placed in a thermostat-controlled water bath
(SC100, Thermo Fisher Scientific, Newington, CT, USA), which
maintained a temperature of 37uC and was used as a cooling
system for the irradiated cultures as previously described [15].
Non-irradiated controls were localized on the same plate and were
kept at a suitable distance from the irradiated wells in order to
avoid any direct and/or indirect irradiation influence (data not
shown). Additionally, the temperature was monitored using a
Voltcraft thermometer (Type 2ABAc, Philips, Kassel, Germany).
Study design
Infection Experiments. The experiments were organized in
four different treatment groups: i) non-infected cells without
irradiation, ii) non-infected cells with irradiation, iii) Chlamydia-
infected cells without, and iv) Chlamydia-infected cells with
irradiation. Vero and HeLa cells were infected with either C.
pecorum or C. trachomatis at 1 multiplicity of infection (MOI) in 1 mL
infection medium (growth culture medium without FCS and
gentamycin). After centrifugation for 1 hour (h) at 1000 g and
25uC, infection medium was replaced by incubation medium
(growth culture medium without gentamycin) containing 1%
cycloheximide (Sigma-Aldrich, Inc., St. Louis, MO, USA) and
cultures were incubated at 37uC as previously described [13].
Irradiation of chlamydial EBs prior to host cell
infection. Chlamydial EBs at MOI 1 were irradiated in 1 mL
infection medium for 20 min at a dose of 3700 W/m2 before
infection of host cells. Non-irradiated EBs were used as controls.
After an incubation period of 43 h, cultures were subjected to i)
immunofluorescence microscopy, or ii) infectious titer analysis, as
appropriate. C. pecorum EBs were used to infect Vero and HeLa
monolayers. C. trachomatis EBs were applied to HeLa cells only.
Single-dose irradiation 40 hours post infection. For
single-dose irradiation, HeLa and Vero monolayers were infected
with C. trachomatis or C. pecorum. After an incubation period of 40 h
at 37uC, cultured cells were irradiated for 20 min (3700 W/m2).
Cultures were incubated for another 3 h at 37uC under standard
culture conditions before being subjected to i) immunofluorescence
microscopy, ii) infectious titer analysis, or (iii) transmission electron
microscopy (TEM) (Figure 1A) if not stated differently. Vero
monolayers were infected with C. pecorum and HeLa cells were
infected with C. trachomatis.
Triple-dose irradiation 24, 36 and 40 hours post
infection. For multiple-dose irradiation, Chlamydia-infected cul-
tures were incubated for 24 h at 37uC. Irradiation was performed
three times, at 24 hours post infection (hpi), 36 hpi and 40 hpi for
20 min with the above mentioned standard dose. At 43 hpi,
cultures were further processed for i) immunofluorescence
microscopy, ii) infectious titer analysis, iii) TEM and iv) cytokine
and chemokine assays (Figure 1B). HeLa cells were infected with
C. trachomatis (Figure 1C).
Cell viability assays
10% Alamar blue dye was added to non-infected cell cultures at
specified times following irradiation. After 3 h of incubation at
37uC, fluorescence was monitored at 530-nm excitation and 590-
nm emission wavelength (LS55 luminescence spectrometer,
Perkin-Elmer) as previously described [16] Dosage and duration
of irradiation depended on the experiment.
wIRA/VIS Inhibits Chlamydia
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Western blot analysis
Western blot experiments were performed to assess molecular
markers of cytotoxicity in irradiated HeLa cells. Non-infected
HeLa monolayers were irradiated for 20 min (3700 W/m2) and
harvested directly into Laemmli buffer at specific time points
depending on the experiment. Samples were further processed and
analyzed as described previously [17]. Proteins were detected
using the following primary antibodies: anti-AKT (11E7, 1:1000;
Cell Signaling, Danvers, MA, USA), anti-pAKT (S473, 1:4000;
R&D Systems, Minneapolis, MN, USA), anti-p38 mitogen-
activated protein kinase (MAPK, 1:1000; Cell Signaling), anti-
phospho-p38 MAPK (Thr180/Tyr182, 1:1000; Cell Signaling),
anti-ERK1/2 (1:1000; R&D Systems), anti-phospho-p44/42
MAPK (ERK1/2, Thr202/Tyr204, 1:1000; Cell Signaling),
anti-actin (clone 4, 1:5000; Millipore, Billerica, MA, USA), anti-
caspase-7 (cleaved, Asp198, 1:1000; Cell Signaling), anti-caspase-9
(cleaved, Asp330, 1:1000; Cell Signaling), anti-LCA/B (G40,
1:1000; Cell Signaling). All secondary antibodies were purchased
from Sigma. Signals were detected by enhanced chemilumines-
cence (ECL; ECL detection kit, Pierce, Rockford, IL, USA).
Samples of H2O2 treated HeLa cells were analyzed in parallel as
positive Western blot controls.
Immunofluorescence microscopy
Monolayers were fixed with absolute methanol (220uC) for
10 min and immunolabelled as described [13]. Briefly, chlamydial
inclusions were detected using a Chlamydiaceae family-specific
mouse monoclonal antibody directed against the chlamydial
lipopolysaccharide (LPS, Clone ACI-P, 1:200; Progen, Heidel-
berg, Germany) and a 1:500 diluted Alexa Fluor 488-conjugated
secondary goat anti-mouse antibody (Molecular Probes, Eugene,
OR, USA). Host and chlamydial DNA were labeled using 1:1000
diluted 49, 6-Diamidin-29-phenylindoldihydrochlorid (DAPI, Mo-
lecular Probes). Coverslips were mounted with FluoreGuard
Mounting (Hard Set, ScyTek Laboratories Inc., Logan, UT,
USA) on glass slides and assessed using a Leica DMLB
fluorescence microscope (Leica Microsystems, Wetzlar, Germany)
under oil immersion at 1000-fold magnification with a 1006
objective (PL FLUOTAR 100x/1.30, OIL, ‘/0.17/D, Leica
Microsystems) and a 106 ocular objective (Leica L-Plan 10x/
25 M, Leica Microsystems). In total, 200 cell nuclei and all
chlamydial inclusions per examined field were counted. Micro-
scopic images were captured with the BonTec measuring and
archiving software (BonTec, Bonn, Germany) using a UI-2250SE-
C-HQ camera (uEye, IDS Imaging Development Systems GmbH,
Obersulm, Germany).
Chlamydial titration by sub-passage
Depending on the experiment, monolayers were scraped at
43 hpi and stored at 280uC, either separately or together with
supernatant, followed by sub-passage on the respective host cell as
previously described [13] with minor modifications: centrifugation
was omitted and the suspension consisting of both cells and
supernatant was sonificated for 5 min (Branson Sonifier 250;
Branson Ultrasonics, Danbury, CT, USA) before reinfection
experiments. Fixation and immunofluorescence staining was
Figure 1. Study Design. (A) Diagram of the infection and single-dose irradiation procedure. Host cells were infected, incubated for 40 h and
irradiated for 20 min. After another incubation period of 3 h, samples were further processed and analyzed. (B) Triple-dose irradiation: general design
is according to A with additional irradiations (20 min) at 24 and 36 hours post infection (hpi). (C) Table shows host cells and chlamydial strains
investigated within this study.
doi:10.1371/journal.pone.0102239.g001
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performed as described above. The number of inclusions in 30
random microscopic fields per sample was determined using a
Leica fluorescence microscope at 200-fold magnification with a
206 objective (PL FLUOTAR 20x/0.50 PH 2, ‘/0.17/B) and a
106 ocular objective (Leica L-Plan 10x/25 M, Leica Microsys-
tems). The number of inclusion-forming units (IFU) in undiluted
inoculum was then calculated and expressed as IFU per ml
inoculum according to previously published methods [18].
Transmission electron microscopy (TEM)
HeLa and Vero monolayers were fixed at 43 hpi in 2.5%
gultaraldehyde (Electron Microscopy Sciences, Ft. Washington,
USA) for 1 h and embedded in epoxy resin (Fluka) by routine
methods. Further preparation and investigation were performed as
described previously [13]. Ultrathin sections (80 nm) were
mounted on gold grids (Merck Eurolab AG, Dietlikon, Switze-
land), contrasted with uranyl acetate dehydrate (Fluka) and lead
citrate (Merck Eurolab AG). The sections were investigated in a
Philips CM10 electron microscope. The total number of bacteria
in ten inclusions per condition was counted. Additionally,
chlamydial bacteria were classified according to their morphology
into EBs (dark, 0.25–0.5 mm), IBs (dark center and pale periphery),
RBs (pale, 0.5–1 mm) and ABs (pale, $2 mm).
Cytokine and chemokine assay
Cytokine and chemokine assays were performed three times to
investigate the host cell response to irradiation, chlamydial
infection and the combination of both, respectively. Following
threefold irradiation, 1 mL of supernatant per well was collected
43 hpi and stored at 280uC until further processing. One
supernatant of each experimental group was thawed and then
filtered by using a 0.2 mm syringe filter (Whatman FP 13/0.2 RC-
2, Sigma-Aldrich) followed by filtration through a 0.1 mm syringe
filter (Whatman Anotop 10, Sigma-Aldrich) to remove all
infectious EBs according to published methods [19]. Cytokines
and chemokines were measured using ProteomeProfiler antibody
arrays (Human Cytokine Array Panel A kit and Human
Chemokine Array Kit, R&D Systems, Minneapolis, MN, USA).
500 m of filtered supernatant per condition was processed
according to manufacturer’s instructions. Signals were detected
by ECL (ECL detection kit, Pierce, Rockford, IL, USA) and
analyzed using Adobe Photoshop CS6. First, the arrays were
validated by evaluating the linearity of the internal assay controls
determined over time for each condition (Figure S2). The mean
pixel density of the positive controls was measured over time using
the Adobe Photoshop histogram tool [20]. The area to be
measured was defined as 28628 pixels encompassing the entire
positive control spot. Subsequently, the mean pixel density of each
spot representing cytokines, chemokines, positive and negative
controls was analyzed after three minutes of exposure to ECL. The
pixel densities of six spots per positive control were averaged and
set to 100%. Two spots per cytokine or chemokine were averaged
and expressed as percentage of the positive control according to
published methods [21].
Statistical analysis
All statistical analyses were performed with PRISM software
(GraphPad, Version 5.0b). If not stated differently, all results are
displayed as means 6 standard deviation (SD) or as means 6
standard error of the mean (SEM) of the indicated number of
experiments. The significance of differences was estimated by t
test, and a p-value of ,0.05 was considered significant.
Results
Irradiation of chlamydial EBs reduces their infectivity on
host cells
To determine the effect of irradiation on Chlamydia alone, we
irradiated EBs of two different chlamydial strains prior to infection
of host cells. First, we infected HeLa monolayers with irradiated C.
trachomatis EBs whereas non-irradiated EBs were used as controls.
Cultures were incubated for 43 h and either collected for sub-
passage analysis, or fixed and immunolabelled directly. The
infectivity rate of irradiated EBs was lower (0.2160.07 inclusions
per nucleus) than that of the controls (0.4160.09 inclusions/
nucleus) (Figure 2A). These findings were further confirmed by
sub-passage analysis. IFU/mL was calculated and expressed as
percentage of the control (34.72%63.24%, Figure 2B), showing
differences between the treated and non-treated groups. In order
to evaluate whether this effect was limited to a specific chlamydial
strain, we infected HeLa monolayers with irradiated C. pecorum
EBs using a similar setting. IFU/mL of irradiated EBs was lower
after titration by sub-passage (76.2%612.11%) compared to
100% of the non-irradiated control (Figure 2C). Furthermore, in
order to exclude that the effect was host cell-related, we used
irradiated C. pecorum EBs to infect Vero cells. The frequency of C.
pecorum chlamydial inclusions per Vero cell nucleus was reduced if
EBs were irradiated prior to infection (0.2660.03 inclusions/
nucleus) compared to non-irradiated C. pecorum control EBs
(0.5360.05 inclusions/nucleus, Figure 2D). Subsequent titration
by sub-passage led to a more pronounced reduction of C. pecorum
EBs in Vero cells (8.0%69.52% compared to 100% of the control,
Figure 2E) than irradiation of C. trachomatis EBs prior to infection
of HeLa cells.
Irradiation of mammalian cells does not induce general
and molecular markers of cytotoxicity
Next, we evaluated the impact of irradiation dose and duration
on two different cell lines (Vero, HeLa) to investigate potential
cytotoxic side effects due to irradiation. First, cell viability was
tested by the Alamar blue assay in the Vero cell line. In these
experiments, we irradiated non-infected Vero cells for 20 min at
doses ranging from 620 to 3700 W/m2, respectively, and
incubated them for 3 h before adding the Alamar blue dye. After
another incubation period of 3 h, we monitored the fluorescence
to quantify cell viability. Heat-denaturated (h.d.) Vero cells were
included within the experiments as controls. The overall cell
viability was not affected by irradiation regardless of the exposure
intensity, even at the highest achievable dose of 3700 W/m2
(Figure 3A). Then we investigated irradiated HeLa cells using the
Alamar blue assay. Irradiation was applied at a dose of 3700 W/
m2 for 20 min as above and irradiation time was extended to 60
and 240 min. Cell viability was assessed 0, 30 min, 6 h and 24 h
after treatment and compared to non-irradiated controls. No
significant decrease of cell viability in any of these settings was
observed (Figures S1A, S1B and S1C).
To gain more information towards possible cell stress signaling
due to irradiation, well-known molecular markers of cytotoxicity
were evaluated in irradiated HeLa cells by Western blot analysis
[22]. HeLa cells exposed to irradiation for 20 min at a dose of
3700 W/m2 were investigated for the presence of phosphorylated
forms of the stress kinases Akt, p38 and ERK 1/2, at 0, 15 and
30 min after irradiation. We observed no difference between
irradiated and non-irradiated cells regarding the phosphorylation
status of Akt, p38 and ERK 1/2 protein (Figure 3B). Samples were
also collected 2, 4, 6 and 24 h after treatment and examined for
autophagy (LC-3B) and apoptosis induction (cleaved Caspases 7
wIRA/VIS Inhibits Chlamydia
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and 9). Irradiation did not induce either apoptosis or autophagy
marker regardless time post-irradiation in HeLa cells (Figure 3C).
A single dose of irradiation reduces the number of
chlamydial inclusions within host cells
After cytotoxic effects on host cells due to irradiation were
precluded, we investigated the effect of a single dose of irradiation
applied to infected cell monolayers. We aimed to determine
whether irradiation has an effect on mature inclusions containing
EBs and RBs within the host cell. We infected HeLa monolayers
with C. trachomatis and irradiated them at 40 hpi for 20 min at a
dose of 3700 W/m2. Parallel non-irradiated but infected HeLa
cultures were used as controls. Similar to previous experiments,
cultures were either collected for sub-passage titer analysis, or fixed
and directly immunolabelled. Again, the frequency of chlamydial
inclusions per nucleus was reduced in irradiated cells (0.2860.02
inclusions/nucleus) compared to non-irradiated C. trachomatis-
infected HeLa cells (0.4460.02) (Figure 4A). These findings were
confirmed by sub-passage titer analysis showing that the IFU/mL
of irradiated cultures was 62.88%68.41% compared to the
control (Figure 4B). The reduction of inclusions per nucleus in
Vero cells infected with C. pecorum was confirmed in parallel
experiments and was similar (0.3560.03 inclusions/nucleus
compared to the control with 0.6960.07) (Figure 4C).
It was possible that irradiation of Chlamydia-infected host cells
induces premature rupture of intracytoplasmic chlamydial inclu-
sions, leading to loss of intact inclusions and subsequent release of
EBs into the supernatant. Therefore, we assessed shedding of EBs
into the supernatant by collecting the supernatant and the infected
cell monolayer as separate fractions and analyzing them individ-
ually by sub-passage titer analysis. IFU was similarly reduced up to
50% by irradiation in both cells and supernatant (52.94%63.13%
reduction in monolayers (Figure 4D) and 59.58%613.27% in
supernatants (Figure 4E)).
Irradiation of chlamydial inclusions at 40 hpi might also reduce
chlamydial infectivity by influencing chlamydial maturation or
inducing persistence/stress, which is characterized by alteration of
the chlamydial developmental cycle and the presence of aberrant
bodies (ABs). Therefore, the ultrastructure of irradiated chlamydial
inclusions at 43 hpi was evaluated and compared to that of the
infected but non-irradiated controls by transmission electron
microscopy (TEM). Vero cells were infected with C. pecorum,
irradiated and processed as described before. First, ten inclusions
for each condition (irradiated inclusions, non-irradiated inclusions)
were picked and the total number of bacteria was counted and
allocated to the different developmental stages (EBs, RBs, IBs,
ABs) according to their morphology. With a total of 4318
chlamydial bodies, inclusions within non-irradiated samples
contained almost as twice as many bacteria as the irradiated
inclusions (2524 chlamydial bodies, Figure 5A). There was no
difference in the distribution of the different chlamydial matura-
tion stages between irradiated and non-irradiated chlamydial
Figure 2. Irradiation of chlamydial EBs reduces their infectivity on host cells. (A) C. trachomatis EBs (MOI 1) were either irradiated or not
prior to infection of HeLa monolayers. Cultures were incubated for 43 hours, fixed, and immunolabelled with anti-chlamydial LPS (green) and DAPI
(blue). Frequency of inclusions per nucleus was calculated (mean 6 SD; * p,0.05; n = 3; t test). Representative microscopic pictures at 10006
magnification are shown additionally in the panel. (B) Cultures were collected and subjected to sub-passage titer analysis. Inclusion forming units
(IFU) are shown as percent of control (mean 6 SD; * p,0.0001; n = 3; t test). (C) C. pecorum EBs were irradiated prior to infection of HeLa monolayers.
Non-irradiated EBs were used as controls. Cultures were collected and subjected to sub-passage titer analysis. Inclusion forming units (IFU) are
presented as percent of control (mean 6 SD; * p,0.05; n = 3; t test). (D) C. pecorum EBs were irradiated or not prior to infection of Vero monolayers.
Cultures were incubated for 43 hours, fixed, and immunolabelled as shown in panel A. Frequency of inclusions per nucleus was calculated (mean 6
SD; * p,0.0025; n = 3; t test). (E) Cultures from panel D were collected and subjected to sub-passage titer analysis. Inclusion forming units (IFU) are
shown as percent of control (mean 6 SD; * p,0.0001; n = 3; t test).
doi:10.1371/journal.pone.0102239.g002
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inclusions. The irradiated inclusions harbored 30%68.85% EBs,
13.4%63.89% IBs, 56.4%611.02% RBs and 1.4% ABs, whereas
the non-irradiated chlamydial inclusions consisted of
29.8%69.91% EBs, 15.3%63.83% IBs, 54.7%610.92% RBs
and 1.4% ABs (Figures 5B and S3A).
Thermal effects of irradiation are responsible for the
reduced chlamydial infectivity
To elucidate the basal mechanism of chlamydial reduction due
to irradiation, we measured the intra-well temperature on top of
the coverslip at the bottom of the well during the 20 min
irradiation period at the applied dose of 3700 W/m2. The
temperature profile started with an initial rise of temperature
from 34.7uC up to 37.6uC during the first 5 min of irradiation.
After ten minutes, the intra-well temperature reached a stationary
phase at 38.4uC and did not exceed 38.8uC within the 20 min
irradiation period. Non-irradiated wells on the same plate were
used as controls. The temperature at the bottom of the control-
wells varied between 35.1uC and 35.9uC within the 20 min time
frame. The temperature raise induced by the irradiation was then
mimicked by heating the water bath to 41uC for 20 min showing
identical temperature kinetics (Figure 5C).
Subsequently, the setting of single-dose irradiation was mim-
icked by placing C. pecorum-infected Vero cells (40 hpi) in a water
bath at 41uC for 20 min without any irradiation. Cultures were
fixed and immunolabelled at 43 hpi as previously described. In
parallel, C. pecorum-infected Vero cultures were kept in a water
bath for 20 min at 37uC (untreated controls). On the same plate,
separate wells containing C. pecorum-infected Vero cells were
irradiated with wIRA/VIS for 20 min (3700 W/m2). The
frequency of chlamydial inclusions was reduced in the tempera-
ture-treated cultures (0.4160.05 inclusions/nucleus) compared to
that of untreated controls (0.6160.02 inclusions/nucleus)
(Figure 5D) similarly to the effect of single-dose irradiation
(0.4760.03 inclusions/nucleus).
The potential cytotoxic effect of the temperature treatment was
evaluated in HeLa cells by testing the cell viability with the Alamar
blue. Non-infected HeLa monolayers were placed in a water bath
at 41uC for 20 min and Alamar blue was added at 0, 30 min, 6
and 24 h after the treatment. We found no decrease of cell
viability at any of the analyzed time points after temperature
enhancement compared to untreated HeLa cells (Figure S1D).
Triple dose of irradiation enhances the effect on
chlamydial inclusions and their maturation stages
Next, we determined whether multiple doses of irradiation
could further reduce the chlamydial inclusion numbers compared
to the single irradiation. To test the impact of multiple doses, C.
trachomatis-infected HeLa cultures were irradiated three times at
24, 36 and 40 hpi for 20 min each at a dose of 3700 W/m2 with
non-irradiated, C. trachomatis-infected HeLa monolayers as con-
trols. Cultures were either collected for sub-passage titer analysis at
43 hpi, or fixed and subsequently immunolabelled according to
our general experimental design (Figure 1). The frequency of
Figure 3. Irradiation of mammalian cells does not induce general and molecular markers of cytotoxicity. (A) Vero cells were irradiated
with the indicated dosage for 20 min. Cell viability was analyzed using Alamar blue dye 3 h after irradiation (mean 6 SD; n.s. non significant; n$3; t
test). Heat-denaturated samples (h.d.) were included as killing controls. (B) HeLa monolayers were irradiated for 20 min with 3700 W/m2 and
subsequently collected at the indicated time points. Western blot analysis of phosphorylated AKT (pAKT), p38 (p-p38) and ERK 1/2 (p-ERK1/2) are
shown. Unphosphorylated proteins are presented as loading controls. (C) Western blot analysis of cleaved Caspase 7 and 9 as well as LC-3B in HeLa
cells after irradiation (20 min) at the indicated time points. Actin was used as loading control.
doi:10.1371/journal.pone.0102239.g003
wIRA/VIS Inhibits Chlamydia
PLOS ONE | www.plosone.org 6 July 2014 | Volume 9 | Issue 7 | e102239
chlamydial inclusions was reduced in irradiated samples
(0.3460.12 inclusions/nucleus) compared to non-irradiated con-
trols (0.5260.06 inclusions/nucleus) (Figure 6A). When inclusions
were counted directly by immunofluorescence microscopy, the
reduction effect of the triple-dose treatment yielded almost
identical reduction (34.62%) compared to single-dose irradiation
(36.36%). However, a more profound decrease in IFU/mL was
observed after threefold irradiation (25.60%69.14%), compared
to that observed after a single dose of irradiation (62.88%68.41%,
Figure 6B)).
Because these data indicate that multiple irradiations have an
additive effect on chlamydial infectivity, we examined the
ultrastructure of threefold-irradiated chlamydial inclusions. HeLa
cells were infected, irradiated three times (24, 36, 40 hpi), fixed
after a 3-hour incubation period and further processed for electron
microscopy at 43 hpi. We counted the total number of bacteria in
irradiated and non-irradiated, Chlamydia-infected cells as previous-
ly described. Containing 4627 chlamydial bodies in total, non-
irradiated inclusions consisted of more than twice as many bacteria
as irradiated inclusions (2179 chlamydial organisms, Figure 6C).
Similar to single-dose irradiation, chlamydial developmental forms
were categorized into different developmental stages (EBs, IBs,
RBs, ABs) according to their morphology. Irradiated inclusions
contained fewer EBs (16.6%69.48%) but a higher amount of RBs
Figure 4. A single dose of irradiation reduces the number of chlamydial inclusions within host cells. (A) C. trachomatis-infected HeLa
cells were either irradiated or not 40 hpi. Cultures were fixed 43 hpi and immunolabelled with anti-chlamydial LPS (green) and DAPI (blue). Frequency
of inclusions per nucleus was calculated (mean6 SD; * p,0.001; n = 3; t test). (B) Infected HeLa cultures were collected and subjected to sub-passage
titer analysis. Inclusion forming units (IFU) are shown as percent of control (mean6 SD; * p,0.0025; n = 3; t test). (C) Vero monolayers infected with C.
pecorum were irradiated 40 hpi. Non-irradiated, C. pecorum-infected cells were used as controls. Cultures were incubated for 46 hours, fixed, and
processed as in panel A (mean 6 SD; * p,0.0025; n = 3; t test). (D) C. pecorum-infected Vero cells were separated from the supernatant, collected
43 hpi and subjected to sub-passage titer analysis. Monolayers were fixed 40 h post reinfection and immunolabelled as shown in panel A. Inclusion
forming units are shown as percent of control (mean6 SD; * p,0.0001; n = 3; t test). Representative microscopic pictures at 10006magnification are
shown additionally in the panel. (E) The supernatant of the infected cells (panel D) was collected separately and subjected to sub-passage titer
analysis. Inclusion forming units are represented as percent of control (mean 6 SD; * p,0.01; n = 3; t test). Representative pictures are presented as
well.
doi:10.1371/journal.pone.0102239.g004
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(60.5%614.52%) compared to the non-irradiated chlamydial
inclusions with 31.3%613.48% EBs and 45.3%612.45% RBs,
respectively. The distribution of IBs was similar in both conditions
with 23.2%66.85% in non-irradiated and 22.8%66.91% in
irradiated inclusions, respectively. The number of ABs was
negligible in both testing conditions (Figures 6D and S3B).
Irradiation and chlamydial infection trigger an identical
subset of released cytokines and chemokines from cells
Finally, to investigate the response of HeLa cells to irradiation,
to chlamydial infection, and to the combination of both, cytokine
and chemokine assays were performed. This experiment included
four different treatment groups: (i) non-infected HeLa cells without
irradiation, (ii) non-infected HeLa monolayers with irradiation, (iii)
Figure 5. Thermal effects of irradiation are responsible for the reduced chlamydial infectivity. (A) C. pecorum-infected Vero cells were
irradiated 40 hpi. Non-irradiated, C. pecorum-infected cells are controls. Cultures were fixed 43 hpi with glutaraldehyde, and further processed as
described in Material and Methods in the transmission electron microscopy section. The total number of bacteria in ten inclusions per condition was
counted: controls (in sum 4318 bacteria) and irradiated inclusions (2524 bacteria). Shown are the means6 SD of ten chlamydial inclusions (* p,0.05,
n = 10; t test). The mid-line shows the median, the box represents the 25th to 75th percentiles whereas the whiskers show the minimum to maximum
values. Representative inclusions are shown additionally in the panel. (B) Chlamydial bacteria within ten inclusions (from A) were split according to
their morphology into elementary bodies (EB), intermediate bodies (IB), reticulate bodies (RB) and aberrant bodies (AB). The graphs show the
distribution of each maturation stage per condition. (C) 1 mL of cell culture medium in a well of a 24-well plate was irradiated or the resulting
temperature enhancement due to irradiation was mimicked using a water bath at 41uC (41uC exposed). Shown is the intra-well temperature at the
indicated time points (mean 6 SD; n.s. non significant, n = 3). (D) Vero cells were infected with C. pecorum, incubated for 40 h and placed in a water
bath at 41uC for 20 min (41uC exposed). In parallel, C. pecorum-infected Vero cultures were placed in a water bath at 37uC for 20 min and were used
as controls. Cultures were subsequently fixed at 43 hpi and immunolabelled with anti-chlamydial LPS (green) and DAPI (blue). Frequency of
inclusions per nucleus was calculated (mean 6 SD; * p,0.005; n = 3; t test).
doi:10.1371/journal.pone.0102239.g005
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C. trachomatis-infected HeLa cultures without irradiation (infected
controls), and (iv) C. trachomatis-infected HeLa cultures with
irradiation. Triple-dose irradiation (24, 36, 40 hpi) was performed
as previously described, the supernatants of each experimental set
were collected at 43 hpi, and cytokines and chemokines were
analyzed using cytokine and chemokine array panel kits according
to manufacturer’s instructions. Beforehand, the arrays were
validated by assessment of the linearity of internal assay controls
determined over time (Figure S2). We observed a similar release
pattern in five out of 20 cytokines (IL-6, IL-8, MIF/GIF,
RANTES, Serpin E1) and in five out of 24 chemokines (ENA-
78, IL-16, IP-10, MIG, MIP-1a/b) in all three treatment groups
(ii)-(iv) (Figure 7A). However, expression of most cytokines and
chemokines tested did not change under the treatment conditions
examined (Figure 7B).
Discussion
Antimicrobial therapy is the treatment of choice for bacterial
infections. However, all pharmacological approaches bear the risk
Figure 6. Triple dose of irradiation enhances the effect on chlamydial inclusions and their maturation stages. (A) C. trachomatis-
infected HeLa cells were irradiated three times at 24, 36 and 40 hpi for each 20 min. Non-irradiated, C. trachomatis-infected cells were used as
controls. Cultures were fixed 43 hpi and immunolabelled with anti-chlamydial LPS (green) and DAPI (blue). Frequency of inclusions per nucleus was
calculated (mean 6 SD; * p,0.01; n = 3; t test). (B) Infected HeLa cultures were collected and subjected to sub-passage titer analysis. Inclusion
forming units (IFU) are presented as percent of control (mean 6 SD; * p= 0.0001; n = 3; t test). (C) Cultures were fixed 43 hpi and further processed to
transmission electron microscopy. The total number of bacteria in ten inclusions per condition was counted: controls (in sum 4627 bacteria) and
irradiated inclusions (2179 bacteria). Shown are the means 6 SD of chlamydial inclusions (* p,0.0005, n = 10; t test). The mid-line shows the median,
the box represents the 25th to 75th percentiles whereas the whiskers show the minimum to maximum values. Representative inclusions are shown
additionally in the panel. (D) Chlamydial bacteria within ten inclusions (from C) were split according to their morphology into elementary bodies (EB),
intermediate bodies (IB) and reticulate bodies (RB). The graphs show the distribution of each maturation stage per condition.
doi:10.1371/journal.pone.0102239.g006
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of unwanted side effects such as antibiotic-associated diarrhea in
patients treated with amoxicillin-clavulanate, or more severe risks
such as cephalosporin-induced (cefotetan) immune hemolytic
anemia, drug-induced liver toxicity due to various antimicrobial
agents (sulfonamides, macrolides, quinolones) and kidney injury
caused by aminoglycosides, vancomycin and others [23].
Chlamydia trachomatis is a known agent of ocular and genital
infections leading to blindness (Trachoma) and sexually transmit-
ted diseases. Recommended antibiotic therapies to treat these
conditions are either by multiple doses of tetracycline or a single
dose of azithromycin [10]. However, a recent study has found that
the risk of cardiovascular death in patients on azithromycin is
elevated, compared to patients treated with amoxicillin or
ciprofloxacin [23], [24]. Another well-known factor limiting the
efficacy of antimicrobial treatment is the development of antibiotic
resistance through acquisition of resistant determinants by
horizontal gene transfer and/or other mechanisms [25].
In veterinary medicine, tetracycline-resistant C. suis strains
carrying the tet(C) resistance gene have been described in the USA
[26] and Europe [27]–[29]. Very recent findings reported C. suis in
the eyes of trachoma patients in Nepal [30], highlighting its
zoonotic potential. Various studies have detected resistance of C.
trachomatis to other antibiotics, such as rifampin, in vitro [6]–[9].
The obligate intracellular lifestyle of chlamydiae poses additional
challenges to antibiotic treatment, as the compound must
Figure 7. Irradiation and chlamydial infection trigger an identical subset of released cyto- and chemokines from cells. HeLa cells were
either infected or not with C. trachomatis and irradiated three times (24, 36 and 40 hpi). Supernatant was collected 43 hpi and cytokines as well as
chemokines were analyzed using cytokine and chemokine array panel kits. (A) All altered cytokines (IL-6, IL-8, MIF/GIF, RANTES, Serpin E1) and
chemokines (ENA-78, IP-10, IL-16, MIG, MIP-1a/b) following (ii) irradiation without chlamydial infection, (iii) infection without irradiation (infected
controls), and (iv) irradiation of Chlamydia-infected HeLa cells (irradiated and infected) compared to (i) untreated controls are shown. The results are
presented as percentage of the positive control (mean6 SEM; n = 3). (B) This table summarizes all tested cytokines and chemokines measured by the
assay with no alteration compared to the controls.
doi:10.1371/journal.pone.0102239.g007
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penetrate the host cell to get access to the membrane-bound
intracytoplasmic inclusion.
Facing all these limitations and drawbacks, alternative thera-
peutic strategies to treat chlamydiae are worth investigating. A
small-molecule inhibitor of type III secretion leading to a dose-
dependent decrease of chlamydial inclusions in acutely infected
host cells was reported by Muschiol et al. [31] and other chemical
inhibitors of chlamydial development are being explored. Unfor-
tunately, there are few other studies investigating non-chemical
agents for inhibition/treatment of chlamydial infections. Ermo-
laeva et al. [32] investigated the effect of non-thermal plasma
(NTP) on C. trachomatis-infected McCoy cells. NTP is «the flow of
partially ionized, neutral gas obtained at atmospheric pressure»
with a temperature of 30–40uC. Infected cells were treated with
NTP 24 hpi for 2 min and medium was subsequently replaced.
Sub-passage titer analysis revealed a reduction by a factor of
1.96106 compared to untreated and argon-treated controls.
Furthermore, the authors could show that treatment of extracel-
lular EBs led to a very low infectivity rate (,0.01%) compared to
untreated controls (,90%). However, there was a decrease of cell
viability of approximately 20% at 24 h after treatment. Wasson et
al. [33] used visible light (violet, 405 nm) to irradiate C. trachomatis-
infected HeLa cells for 88 seconds (s) using different exposure
intensities (5, 10, 20 J/cm2) at 2 and 24 hpi, respectively. Using
quantitative real-time PCR, they found an inhibitory effect on
chlamydial growth in acute and penicillin-induced persistent
infections after irradiation. Interestingly, a clinical study found
evidence for a lower rate of wound infection following abdominal
surgery when patients were subjected to the combination of wIRA
(780–1400 nm) and visible light (VIS, 590–780 nm) postopera-
tively twice a day for 20 min [11]. In the present study, we
demonstrate that irradiation of chlamydial EBs with wIRA/VIS
prior to infection of cell cultures reduces their infectivity,
regardless of the chlamydial strain and the host cell used. We
observed a 65% reduction of IFU/mL when irradiated C.
trachomatis EBs were propagated in HeLa cells and a 90% IFU
reduction when irradiated C. pecorum EBs were inoculated into
Vero cells. Taken together, our findings show that wIRA/VIS-
exposure can significantly reduce infectivity of extracellular
infectious EBs. Thus, wIRA/VIS irradiation might prove bene-
ficial for inhibiting the transmission of EBs.
We further investigated the effect of single-dose treatment
(3700 W/m2, 20 min) on fully developed chlamydial inclusions.
We investigated two different mammalian cell lines (HeLa, Vero)
and two different chlamydial strains (C. trachomatis, C. pecorum). Our
findings demonstrate that a single dose of wIRA/VIS irradiation is
sufficient to reduce the amount of chlamydial inclusions in vitro
regardless of the infection model. Sub-passage titer analysis of
irradiated C. pecorum-infected Vero cells was performed separately
for cells and supernatant. Because we observed similar infectivity
reduction in both cell monolayers and supernatants, it seems
unlikely that the wIRA/VIS-mediated decrease in inclusion
number is due to premature inclusion rupture and subsequent
loss of inclusions from the monolayer. Furthermore, we show here
an accumulating effect of irradiation by applying multiple wIRA/
VIS doses in the course of the infection cycle.
Chlamydiae are not only associated with acute infections but
also with a variety of chronic diseases characterized by scarring
and inflammation, which result in considerable damage to the
host. One example of this process is tubal infertility subsequent to
C. trachomatis-induced pelvic inflammatory disease. A number of in
vivo and in vitro studies suggest that chlamydiae remain in a non-
infectious but viable developmental state (termed either persistence
or the chlamydial stress response) during chronic infections [34].
Galasso and Manire [35] demonstrated first that penicillin-
exposed C. psittaci enters a non-infectious but viable state in vitro.
Removal of the stressor led to normal progression of the
chlamydial development cycle. Since 1961, various stressors
responsible for persistence induction in vitro have been reported
such as amino acid or iron deficiency, IFN-c exposure, monocyte
infection and heat shock [5], [34]. Kahane and Friedman [36]
transferred C. trachomatis-infected BGM cells to 42uC inducing heat
shock. They demonstrated that prolonged exposure to tempera-
tures of 42uC for more than 9 h results in stagnation of the growth
cycle and loss of infectivity. Cultures exposed to heat shock for 2 h
revealed regular distribution of EBs and RBs whereas cultures
treated with 42uC for 5 h predominantly displayed aberrant
bodies. In our study, persistence induction and occurrence of ABs
was excluded by TEM analysis. No difference in AB frequency
was observed between irradiated and non-irradiated cells under
any experimental condition tested (i.e. neither single dose in Vero
cells infected with C. pecorum, nor multiple doses in C. trachomatis
infected HeLa cells). We could further demonstrate that single
dose irradiation reduces the total amount of organisms by about
50% compared to non-irradiated C. pecorum inclusions, without
altering the distribution of EBs and RBs. Non-irradiated C.
trachomatis inclusions harbored more than twice as many
chlamydiae compared to three times irradiated inclusions.
Moreover, three times irradiated C. trachomatis inclusions contained
fewer EBs and a higher amount of RBs. The absolute number of
irradiated RBs was reduced compared to non-irradiated RBs,
however. Taken together, we show that irradiation diminished the
total amount of chlamydial developmental forms by an unknown
mechanism without inducing chlamydial persistence.
The present study investigated not only the effect of wIRA/VIS
on chlamydiae, but also examined the host cell response under
wIRA/VIS treatment. Thus, the influence of irradiation on two
different host cell types was evaluated by cell viability assays as well
as Western Blot analysis of cellular stress markers. We demonstrate
that host cell viability was not altered by irradiation even at the
highest possible dosage of 3700 W/m2 and during long-time
exposure of 4 h. These findings are in line with a study by Jung et
al. [15]. They investigated the effect of wIRA irradiation at 2100–
2400 W/m2 for up to 4 h on human fibroblasts. Recent studies
have shown the induction of MMP-1 due to infrared A irradiation
[37], [38]. Matrix Metalloproteinase (MMP)-1 contributes to
premature skin aging and is expressed as response to ultraviolet
radiation (UV) A and UV B [39]. Additionally, Schieke et al. [37]
reported rapid activation of extracellular signal-regulated kinase
1/2 (ERK 1/2) and p38-mitogen-activated protein kinase (p38) by
phosphorylation within 15 min after exposure to infrared A. They
further demonstrate that expression of MMP-1 is directly
regulated by the ERK 1/2 pathway. In our study, we investigated
phosphorylation of ERK 1/2, p38 and Akt in order to examine
possible stress response signaling due to wIRA/VIS irradiation.
Neither of those stress kinases was activated by irradiation up to
30 min after treatment. Another stress response of cells is the
occurrence of autophagy, an organized, endogenous clearance
pathway within cells. During autophagy, damaged cell structures
are removed by transportation to lysosomes and subsequent
degradation [40]. In this study, we included Western blot analysis
of LC-3B conversion as a marker of autophagy and detected no
signs of autophagy induction in irradiated HeLa cells up to 24 h
post treatment. Finally, we assayed cleaved Caspase 7 and 9, as
additional sensors of apoptotic cell death. As expected, none of
these cell death proteases were activated by wIRA/VIS treatment.
Taken together, these data demonstrate that wIRA/VIS does not
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induce cytotoxicity within host cells at an exposure intensity of
3700 W/m2 over the course of 20 min and beyond.
Next, we studied the effect of wIRA/VIS on the host cell
cytokine and chemokine response in HeLa cells that were either
mock-infected or infected with C. trachomatis. In general, bacterial
infections induce a pro-inflammatory response within host cells
leading to activation of the immune system and subsequent
elimination of the pathogens unless the pathogens possess
appropriate evasion strategies. Whereas numerous studies have
investigated the interaction between host cells and Chlamydia, the
general importance of pro-inflammatory response to control
chlamydial infection is still controversial [41]. Studies investigating
the cytokine and chemokine response to chlamydial infection have
shown up-regulation of IL-1a, IL-6, IL-11, TGF-b1, GM-CSF,
GRO-a and IL-8 in C. trachomatis-infected HeLa cells [42]. In our
study, we compared the cytokine and chemokine pattern of (ii)
non-infected, wIRA-irradiated HeLa cells, (iii) C. trachomatis-
infected, non-irradiated and (iv) infected, irradiated cultures to (i)
non-infected, non-irradiated HeLa cell monolayers. Irradiation
was performed three times (24, 36, 40 hpi) and supernatant was
collected for subsequent cytokine and chemokine analysis at
43 hpi. Compared to group (i), we observed increased secretion of
five cytokines (MIF/GIF, Serpin E1, RANTES, IL-6, IL-8) and
five chemokines (ENA-78, IL-16, IP-10, MIG, MIP-1a/b)
following wIRA/VIS-exposure, chlamydial infection or both.
We observed an increase of pro-inflammatory IL-6 and IL-8 in
Chlamydia-infected cells. These results are consistent with previ-
ously published observations [19], [21], [43]–[46]. We also
detected a thermal-induced increase of IL-6 and IL-8 due to
wIRA/VIS irradiation. Jiang et al. [47] also reported an up-
regulation of IL-6 in mice following challenge with LPS and
subsequent elevation of their core temperature to 39.5–40uC. In
contrast, Shah et al. [48] found no change of IL-6 and IL-8 in
HUVEC cells after treating them with an elevated temperature of
40uC for 6 to 12 h.
IL-1a is another pro-inflammatory cytokine strongly interacting
with IL-6 and IL-8. Its up-regulation in Chlamydia-infected cells has
been shown previously in numerous studies [19], [43], [45]. It is
released into the supernatant at the end of the chlamydial
developmental cycle [45]. The longest incubation period in our
setting was 46 hpi and as expected, we did not find an increased
secretion of IL-1a.
We also detected an increase of MIF/GIF after chlamydial
infection, a pro-inflammatory cytokine promoting the production
of tumor necrosis factor (TNF), IFN-c, IL-1b, IL-2, IL-6 and IL-8
[49]. To¨rma¨nkangas et al. [21] has reported similar results in C.
pneumoniae-infected Calu3 cells whereas Johnson [50] found no
change of MIF/GIF in murine oviduct cells infected with C.
muridarum up to 24 hpi.
We found an increased secretion of RANTES in Chlamydia-
infected cells. Other authors have shown similar data [50], [51],
but Buckner et al. [19] demonstrated a decrease of RANTES
secretion in human polarized endocervical epithelial cells
(polA2EN) infected with C. trachomatis. Furthermore, wIRA/VIS
treatment alone induced RANTES. In contrast, Shah et al. [48]
found no alteration of RANTES excretion in thermally treated
(40uC for 6 to 12 h) primary endothelial cells (HUVEC).
Following chlamydial infection, we further observed a secretion
of pro-inflammatory IP-10 (CXCL 10). These results are in line
with other authors [21], [50],[51]. In contrast, Buckner et al. [19]
found a decrease of IP-10 secretion in C. trachomatis-infected
polA2EN cells. MIG (CXCL 9) is an angiostatic and chemotactic
substance closely related to IP-10 [52] and its increase after
chlamydial infection was demonstrated in our study as well as in
previous publications [50], [51]. Additionally, wIRA/VIS irradi-
ation alone caused a similar secretion of MIG and IP-10 in HeLa
cells whereas Shah et al. [48] found no change in the secretion of
MIG 10 h after treating HUVEC cells with 40uC for 6 to 12 h.
In our study, we observed a release of MIP-1a/b (CCL3/4) into
the supernatant after chlamydial infection and/or irradiation.
MIP-1a/b is known to be chemotactic for natural killer (NK) cells
[42]. Regulation of MIP-1a/b was unaltered by chlamydial
infection in murine oviduct cells and McCoy cells [50], [51]. In
contrast, up-regulation of MIP-1a/b gene expression has been
reported in cervical tissue of mice after infection with C. muridarum
at 2 and 6 hpi [53]. MIP-1a/b remained unchanged in HUVEC
cells when they were incubated at 40uC for 6 and 12 h and
measured 10 h after treatment [48].
ENA-78 (CXCL5) is a pro-inflammatory chemokine associated
with neutrophil chemotaxis. In a clinical study investigating active
trachoma, gene expression of ENA-78 was increased [54]. The
authors postulated that ENA-78 might contribute to fibrosis. An
increase of ENA-78 gene expression was found at approximately
24 hpi when mice were intra-cervically infected with C. muridarum
[53].
Serpin E1, also named plasminogen activator inhibitor-1 (PAI-
1, SERPINE1), is a known pro-fibrotic factor [55]. To our
knowledge, there is no study so far reporting an increase of Serpin
E1 due to chlamydial infection. Yang et al. [56] stimulated HeLa
cells with IL-1b and analyzed the cytokine pattern, reporting no
change between the untreated control group and IL-1b-stimulated
HeLa cells.
Taken together, we observed a similar pro-inflammatory host
cell response in (ii) irradiated but non-infected HeLa monolayers,
(iii) non-irradiated, C. trachomatis-infected cultures and the combi-
nation of both, (iv) irradiated and infected HeLa cells.
Finally, we tried to get insight into the potential mechanism of
wIRA/VIS on infected host cells. In a previous study, Hartel et al.
[11] found a significant increase of subcutaneous oxygen partial
pressure and temperature on the skin surface of patients after
wIRA/VIS irradiation. Patients underwent abdominal surgery
followed by regular postoperative management. Additionally,
patients were irradiated twice a day with either visible light
(control group) or the combination of both, visible light and wIRA.
Subcutaneous temperature was increased from approximately
36uC up to 39uC within 20 min of irradiation compared to the
control. These findings support our results regarding the measured
temperature increase from 35uC up to approximately 39uC during
the wIRA/VIS irradiation (20 min). We mimicked the tempera-
ture increase by placing C. pecorum-infected Vero cultures in a
water bath at 41uC. The results were similar to those following
single dose irradiation, indicating that the inhibitory effect of
wIRA/VIS on chlamydial inclusions might be explained by the
induction of currently unknown thermal effects. According to our
experimental setting, these wIRA/VIS-induced thermal effects led
to a diminished infectivity of EBs. Furthermore, the effect of a
single dose of irradiation on fully developed inclusions (40 hpi)
might have been caused by an inhibition of the RB replication or
the RB to EB transition. Additional wIRA/VIS treatment at 24
and 36 hpi might support these hypotheses as C. trachomatis-
infected HeLa cells mainly consist of RBs at 24 hpi and begin to
differentiate into EBs at 36 hpi [14].
In summary, we demonstrated that wIRA/VIS irradiation
reduces the infectivity of EBs compared to untreated control EBs
regardless of the chlamydial strain (C. pecorum, C. trachomatis). We
further show that wIRA/VIS does not induce cytotoxicity in two
different cell lines (Vero, HeLa) even at high doses of wIRA/VIS
and long-time exposure. Furthermore, we demonstrated that a
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single dose of irradiation applied at a late stage of the chlamydial
developmental cycle (40 hpi) diminished the number of chlamydial
bodies within an inclusion and reduced the total amount of
inclusions in infected cell cultures. Multiple-dose irradiation (24,
36, 40 hpi) resulted in an even more profound reduction without
inducing persistence. Chlamydial infection and/or wIRA/VIS
irradiation triggered an identical, pro-inflammatory host cell
response as observed by the release of a similar cytokine and
chemokine pattern. We suggest further studies are required to fully
elucidate the mechanism behind our findings.
Supporting Information
Figure S1 Additional Viability Assays. (A) HeLa cells were
irradiated for 20 min (3700 W/m2). Cell viability was analyzed
using Alamar blue dye at the indicated time points after irradiation
(mean 6 SD, n= 2) according to the scheme in the upper panel.
Untreated controls are set to 100%. (B) HeLa monolayers were
irradiated for 1 h and cell viability was determined using Alamar
blue at the indicated time points after irradiation as shown in the
upper panel. The means 6 SD of three determinations within the
same experiment are presented. Untreated controls are set to
100%. (C) HeLa cells were irradiated for 4 h and cell viability was
analyzed at the indicated time points after irradiation (scheme).
The means 6 SD of three determinations within the same
experiment are shown. (D) HeLa monolayers were placed in a
water bath at 41uC for 20 min and the cell viability was
determined at the indicated time points. The means 6 SD of
three determinations within one experiment are illustrated.
(TIF)
Figure S2 Validation of cytokine and chemokine arrays.
HeLa cells were either infected or not with C. trachomatis and
irradiated three times (24, 36 and 40 hpi). Supernatant was
collected 43 hpi. Cytokines (A) and chemokines (B) were analyzed
using cytokine and chemokine array panel kits. The linearity of the
internal assay controls determined over time is shown.
(TIF)
Figure S3 The effect of wIRA/VIS on chlamydial
maturation stages. (A) C. pecorum-infected Vero cells were
irradiated 40 hpi. Non-irradiated, C. pecorum-infected cells are
controls. Cultures were fixed 43 hpi with glutaraldehyde, and
further processed as described in Material and Methods in the
transmission electron microscopy section. Chlamydial bacteria
within ten inclusions were split according to their morphology into
elementary bodies (EB), intermediate bodies (IB), reticulate bodies
(RB) and aberrant bodies (AB). The graph shows the distribution
of each maturation stage per condition (mean6 SD; n= 10). (B) C.
trachomatis-infected HeLa cells were irradiated three times at 24, 36
and 40 hpi for each 20 min. Non-irradiated, C. trachomatis-infected
cells were used as controls. Cultures were fixed 43 hpi and further
processed to transmission electron microscopy. Chlamydial
bacteria within ten inclusions were split according to their
morphology as described in (A). The graph shows the distribution
of each maturation stage per condition (mean 6 SD; n= 10).
(TIF)
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